Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Merrimack Pharmaceuticals Inc (NQ: MACK ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Merrimack Pharmaceuticals Inc < Previous 1 2 Next > MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q1 2024 May 16, 2024 Merrimack Pharmaceuticals just reported results for the first quarter of 2024. Via InvestorPlace Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock May 10, 2024 From Merrimack Pharmaceuticals, Inc. Via Business Wire Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution May 09, 2024 From Merrimack Pharmaceuticals, Inc. Via Business Wire Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution April 30, 2024 From Merrimack Pharmaceuticals, Inc. Via Business Wire Merrimack Receives $225 Million Milestone Payment from Ipsen March 27, 2024 From Merrimack Pharmaceuticals, Inc. Via Business Wire Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) Highlighted for Surprising Price Action March 25, 2024 Via Investor Brand Network MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q4 2023 March 08, 2024 Merrimack Pharmaceuticals just reported results for the fourth quarter of 2023. Via InvestorPlace Merrimack Reports Full Year 2023 Financial Results March 07, 2024 From Merrimack Pharmaceuticals, Inc. Via Business Wire Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) February 13, 2024 From Merrimack Pharmaceuticals, Inc. Via Business Wire $2M Bet On Ford? Check Out These 4 Stocks Insiders Are Buying December 12, 2023 Although U.S. stocks closed higher on Monday, there were a few notable insider trades. Via Benzinga Merrimack Reports Third Quarter 2023 Financial Results November 02, 2023 From Merrimack Pharmaceuticals, Inc. Via Business Wire Pancreatic Cancer Battle Boosted by $200M VC Firm September 19, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:MACK),(NASDAQ:INCY),(NASDAQ:MRTX),(NASDAQ:BNTX) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death Merrimack Reports Second Quarter 2023 Financial Results August 03, 2023 From Merrimack Pharmaceuticals, Inc. Via Business Wire Merrimack Reports First Quarter 2023 Financial Results May 04, 2023 From Merrimack Pharmaceuticals, Inc. Via Business Wire Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket March 15, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 15, 2023 We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning! Via InvestorPlace Luna Innovations, Guess? And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session March 15, 2023 U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Merrimack Reports Full Year 2022 Financial Results March 09, 2023 From Merrimack Pharmaceuticals, Inc. Via Business Wire 3 Stocks Insiders Are Buying: Triumph Financial And More February 01, 2023 Although US stocks closed higher on Tuesday, there were a few notable insider trades. Via Benzinga $2.6M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying January 18, 2023 Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades. Via Benzinga Insiders Buying Heska, B. Riley Financial And 2 Other Stocks January 10, 2023 Although US stocks closed mixed on Monday, there were a few notable insider trades. Via Benzinga $1.4 Million Bet On Joint Corp? Check Out These 3 Stocks Insiders Are Buying January 04, 2023 Although US stocks closed lower on Tuesday, there were a few notable insider trades. Via Benzinga Merrimack Pharmaceuticals Extends Section 382 Net Operating Loss Rights Plan December 05, 2022 From Merrimack Pharmaceuticals, Inc. Via Business Wire Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer November 15, 2022 FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 15, 2022 – USA News Group – Roughly five years after selling its flagship cancer asset Onivyde from to French biotech... Via FinancialNewsMedia Topics Death Exposures Death Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer November 10, 2022 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MACK),(NASDAQ:NRBO),(NYSE:MRK),(NASDAQ:RNAZ), EQNX::TICKER_END Via FinancialNewsMedia Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday November 10, 2022 Gainers Via Benzinga Nasdaq Drops 200 Points; Meta Platforms Shares Jump November 09, 2022 U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session November 09, 2022 Gainers Via Benzinga Crude Oil Down Over 2%; Outset Medical Shares Spike Higher November 09, 2022 U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections. Via Benzinga Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session November 09, 2022 Gainers Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.